Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATL-104 for Oral Mucositis in PBSCT Patients
NCT00163280Phase 2Completed
- Sponsor
- Alizyme
- Start
- Jul 2004
- Primary completion
- Dec 2005
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of ATL-104 in oral mucositis (OM), sponsored by Alizyme. Started Jul 2004; status: completed.
02
Drugs
ATL-104
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00163280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00163280.